The MOA prediction platform leverages our patent pending Contingent-AI™ framework to predict molecular mechanism underlying phenotypic screens and follow-on assays.



With BioSymetrics MOA prediction platform, small molecule phenotypic screens are processed through the below workflows:

  • Clustering public datasets
  • Denoising datasets
  • Cluster enrichment
  • Ranked compound listing
  • Bias detection engine

Common Data Types:

  • Animal models
  • Cell culture models


In usually less than three weeks, the MOA prediction platform will generate a detailed reporting dashboard including target/pathway predictions and accelerated hit prioritization.

Time and Price is dependent on complexity of data and compute requirements.
Contact us to learn more and receive an accurate quote.

Get Info/Pricing

Apart from innovating the novel drug discovery process using Contingent-AI™ machine learning techniques, the MOA prediction platform is also used in drug repurposing/ drug repositioning as it can facilitate the discovery of new mechanisms of action for old drugs as well as new classes of medicines.

Explore other Products
Customize your Solution



Novel Drug Discovery

  • Identification of mechanism of action (MOA)
  • Virtual drug screening
  • Hit Expansion
  • Pathway elucidation
  • Toxicity prediction
  • In Silico library screening
  • Library prioritization

Drug Repurposing / Drug Repositioning

  • Polypharmacology
  • Multilabel classification
  • Side effect prediction
  • Off-target prediction
Request MOA Platform Pricing